BRCA1 and cancer: Interestingly, although the TNBC cell line HCC-1937 carries a BRCA1 mutation, it was the least sensitive cell line to olaparib among all cell lines tested, suggesting that factors other than BRCA mutations affect cancer cell sensitivity to olaparib, as also shown by other researchers [7].